BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 6656850)

  • 21. [Effects of treatment with glipizide-metformin on the behavior of blood sugar, insulin and lipids after intravenous administration of glucose in diabetic subjects].
    Ferlito S; Lunetta M; Mangiagli P; Tranchida ML
    G Clin Med; 1974 Nov; 55(11):798-818. PubMed ID: 4469884
    [No Abstract]   [Full Text] [Related]  

  • 22. Kidney disease in KK mice: effect of glipizide.
    Reddi AS; Velasco CA; Khan MY; Bloodworth JM; Camerini-Davalos RA
    Adv Exp Med Biol; 1988; 246():305-12. PubMed ID: 3250259
    [No Abstract]   [Full Text] [Related]  

  • 23. Monozygotic triplets with discordance for diabetes mellitus and diabetic microangiopathy.
    Ganda OP; Soeldner JS; Gleason RE; Smith TM; Kilo C; Williamson JR
    Diabetes; 1977 May; 26(5):469-79. PubMed ID: 192616
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A clinical trial with glipizide - a relative new sulphonylurea.
    Singarayar J; Sunderam S
    Med J Zambia; 1978; 12(4):97. PubMed ID: 398642
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Capillary basement membranes and diabetic microangiopathy.
    Siperstein MD
    Adv Intern Med; 1972; 18():325-44. PubMed ID: 4197108
    [No Abstract]   [Full Text] [Related]  

  • 26. The effect of diabetic control on the width of skeletal-muscle capillary basement membrane in patients with Type I diabetes mellitus.
    Raskin P; Pietri AO; Unger R; Shannon WA
    N Engl J Med; 1983 Dec; 309(25):1546-50. PubMed ID: 6361554
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Microvascular pathology in patients with abnormal glucose tolerance.
    Davis E; Herman JB
    Isr J Med Sci; 1972 Jun; 8(6):772. PubMed ID: 5051784
    [No Abstract]   [Full Text] [Related]  

  • 28. [Our experience in treating diabetes mellitus with the preparation Minidiab].
    Tsanev A; Lazarov G; Manolov D; Daskalova I; Kolebinov N
    Vutr Boles; 1988; 27(2):89-93. PubMed ID: 3414105
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Early capillary changes in diabetes mellitus.
    Amherdt M; Scherrer JR; Rufener C; Pometta D
    Acta Diabetol Lat; 1971 Sep; 8 Suppl 1():88-116. PubMed ID: 5146923
    [No Abstract]   [Full Text] [Related]  

  • 30. Plasma glucagon and clinical control of maturity-onset type diabetes. Effects of diet, placebo and glipizide.
    Lecomte MJ; Luyckx AS; Lefebvre PJ
    Diabete Metab; 1977 Dec; 3(4):239-43. PubMed ID: 340296
    [No Abstract]   [Full Text] [Related]  

  • 31. Blind alleys in diabetes research: muscle capillary basement membrane thickening: marker of microvascular complications or false prophet?
    Dornan TL; Tattersall RB
    Diabet Med; 1986; 3(5):413-8. PubMed ID: 2951192
    [No Abstract]   [Full Text] [Related]  

  • 32. The pharmacology of S 1702, a new highly effective oral antidiabetic drug with unusual properties. 2. Protective activity of S 1702 on the microvascular system in normal and diabetic rats.
    Duhault J; Lebon F
    Arzneimittelforschung; 1972 Oct; 22(10):1686-90. PubMed ID: 4677057
    [No Abstract]   [Full Text] [Related]  

  • 33. Thickening of the capillary basement membrane of the quadriceps muscle in Vacor-induced diabetic patients.
    Lee TH; Choi KC; Park YK; Choi JK
    Diabetes Res Clin Pract; 1985 Oct; 1(3):155-9. PubMed ID: 3836103
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Deterioration of tolerance to glucose and progression of the microangiopathy: effect of treatment (preliminary report).
    Camerini-Dávalos RA; Bloodworth JM; Linburg B; Gordon AL; Cole HS; Oppermann W
    Adv Metab Disord; 1973; 2():Suppl 2:373-82. PubMed ID: 4720374
    [No Abstract]   [Full Text] [Related]  

  • 35. Muscle capillary basement membrane width in genetic prediabetes.
    Camerini-Davalos RA; Oppermann W; Rebagliati H; Glasser M; Bloodworth JM
    J Clin Endocrinol Metab; 1979 Feb; 48(2):251-9. PubMed ID: 429479
    [No Abstract]   [Full Text] [Related]  

  • 36. Skeletal muscle basement membrane in maturity-onset diabetes in the young.
    Mauer M; Steffes M; Johnson E; Rich S; Hoogwerf B; Chavers B; Barbosa J
    Diabetes; 1985 Apr; 34(4):321-5. PubMed ID: 3882497
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Microangiopathy in primary hyperlipoproteinemia.
    Romics L; Neumark T
    Acta Biomed Ateneo Parmense; 1995; 66(3-4):185-8. PubMed ID: 8578936
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Capillary permeability and blood flow in skeletal muscle of patients with diabetes mellitus and genetic prediabetes.
    Alpert JS; Coffman JD; Balodimos MC; Koncz L; Soeldner JS
    N Engl J Med; 1972 Mar; 286(9):454-60. PubMed ID: 4550615
    [No Abstract]   [Full Text] [Related]  

  • 39. Capillary basement membrane thickness in early diabetes.
    Pometta D; Amherdt M; Rufener C; Scherrer JR
    Adv Metab Disord; 1973; 2():Suppl 2:357-61. PubMed ID: 4720372
    [No Abstract]   [Full Text] [Related]  

  • 40. Muscle capillary basement membrane width in patients with vacor-induced diabetes mellitus.
    Feingold KR; Lee TH; Chung MY; Siperstein MD
    J Clin Invest; 1986 Jul; 78(1):102-7. PubMed ID: 3722372
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.